Medications like glucagon-like peptide 1 (GLP-1)-receptor agonists (GLP-1RAs) are also beneficial for the comorbidities associated with obesity, like cardiovascular diseases. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.